1. Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells
   A. Tachtsidis et al, 2016, Clinical & Experimental Metastasis CrossRef
2. p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
   Freda Halim et al, 2022, F1000Research CrossRef
3. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review
   Heewa Shakib et al, 2019, Endocrine CrossRef
4. FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression
   Elena Ricci et al, 2022, Cancers CrossRef
5. The Role of Adipose-Derived Stem Cells in Breast Cancer Progression and Metastasis
   Riccardo Schweizer et al, 2015, Stem Cells International CrossRef
6. Proposing Specific Neuronal Epithelial-to-Mesenchymal Transition Genes as an Ancillary Tool for Differential Diagnosis among Pulmonary Neuroendocrine Neoplasms
   Tabatha Gutierrez Prieto et al, 2022, Genes CrossRef
7. Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion
   Marina Di Domenico et al, 2017, Oncotarget CrossRef
8. PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
   Daniela Miricescu et al, 2020, International Journal of Molecular Sciences CrossRef
9. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells
   Anne-Sophie Bach et al, 2015, Oncotarget CrossRef
10. p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer
    Freda Halim et al, 2022, F1000Research CrossRef
11. Epithelial-mesenchymal transition transcription factors and miRNAs: “Plastic surgeons” of breast cancer
    Caroline Moyret-Lalle, 2014, World Journal of Clinical Oncology CrossRef
12. Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison
    Tania Fiaschi et al, 2012, International Journal of Cell Biology CrossRef
13. Towards Resolving the Pro- and Anti-Tumor Effects of the Aryl Hydrocarbon Receptor
    Supraja Narasimhan et al, 2018, International Journal of Molecular Sciences CrossRef
14. Dexmedetomidine ameliorates high glucose-induced epithelial-mesenchymal transformation in HK-2 cells through the Cdk5/Drp1/ROS pathway
    Fei Wang et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef